BCMU
VIRX

BlueCrest Capital Management (UK)’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-136
Closed -$141K – 434
2013
Q3 		$141K Buy
+136
New +$141K 0.01% 277